Axim Biotechnologies, Inc.
AXIM OTC
SEC CIK 1514946
Follow Axim Biotechnologies
Weekly email: filings, results, news
Revenue, last quarter
$17.5K
+76% vs same quarter last year
Net income
−$2.3M
+39% vs same quarter last year
EPS, diluted
−$0.01
+50% vs same quarter last year
Operating cash flow
−$261.5K
+59.4% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY23 | $7.4K | −$2.8M |
| FY22 | $8.9K | −$6.2M |
| FY21 | $60.5K | −$16M |
| FY20 | $0 | −$6.4M |
| FY19 | $799.5K | −$6.4M |
| FY18 | $195.6K | −$6.8M |
| FY17 | $47.6K | −$4.2M |
| FY16 | $47.1K | −$5.8M |
| FY15 | $49.1K | −$10.1M |
| FY14 | $0 | −$582.9K |
| FY13 | $21.7K | −$89.2K |
| FY12 | $43.3K | −$14.9K |
| FY11 | $10K | −$2.8K |
| FY10 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY23 | - | −9607.1% | −37348% |
| FY22 | - | −52425.6% | −70343.1% |
| FY21 | - | −23114.5% | −26517.2% |
| FY20 | - | - | - |
| FY19 | 0% | −388.9% | −806.5% |
| FY18 | 95.6% | −2574.5% | −3453% |
| FY17 | 9.9% | −6619.5% | −8761.7% |
| FY16 | −227.5% | −7988.8% | −12346% |
| FY15 | −2.5% | −20451.3% | −20539.2% |
| FY14 | - | - | - |
| FY13 | - | - | −411.8% |
| FY12 | - | - | −34.4% |
| FY11 | - | - | −27.9% |
| FY10 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY23 | −$1M |
| FY22 | −$2.1M |
| FY21 | −$2.5M |
| FY20 | −$3.3M |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | −$1.3M |
| FY15 | −$1.6M |
| FY14 | −$339K |
| FY13 | - |
| FY12 | - |
| FY11 | - |
| FY10 | - |
- Axim Biotechnologies
- Healthcare median
Show the numbers
| Year | Axim Biotechnologies | Healthcare median |
|---|---|---|
| FY23 | −37348% | −97.1% |
| FY22 | −70343.1% | −128.5% |
| FY21 | −26517.2% | −129.2% |
| FY20 | - | −136.5% |
| FY19 | −806.5% | −133.7% |
| FY18 | −3453% | −173.4% |
| FY17 | −8761.7% | −176.7% |
| FY16 | −12346% | −164.8% |
| FY15 | −20539.2% | −183.4% |
| FY14 | - | −133% |
| FY13 | −411.8% | −88.5% |
| FY12 | −34.4% | −87.4% |
| FY11 | −27.9% | −76.3% |
| FY10 | - | - |
News
No stories filed under Axim Biotechnologies yet - coverage appears here as the news feed clusters it.